Jun 16, 2026 04:02PM
Jun 16, 2026 04:01PM
May 21, 2026 05:36PM
May 21, 2026 05:17PM
May 12, 2026 07:02AM
May 12, 2026 07:00AM
May 5, 2026 04:01PM Rigel Reports First Quarter 2026 Financial Results
Mar 31, 2026 08:07AM
Mar 31, 2026 08:05AM
Mar 3, 2026 04:01PM
Jan 12, 2026 08:07AM
Jan 12, 2026 08:05AM
Dec 7, 2025 09:30AM
Dec 7, 2025 09:30AM Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
Nov 17, 2025 08:05AM
Nov 17, 2025 08:05AM
Nov 4, 2025 04:01PM
Nov 3, 2025 09:05AM
Oct 9, 2025 06:42AM
Oct 8, 2025 08:05AM
Oct 8, 2025 08:05AM Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
Aug 5, 2025 04:01PM
May 22, 2025 05:21PM
May 22, 2025 05:20PM
May 6, 2025 04:01PM
Mar 27, 2025 08:05AM
Mar 27, 2025 08:05AM
Mar 10, 2025 08:07AM Rigel Pharma (RIGL) Appoints Mark W. Frohlich, M.D. to Board of Directors
Mar 10, 2025 08:05AM
Mar 5, 2025 06:51AM
Mar 4, 2025 04:01PM
Jan 22, 2025 08:05AM
Jan 22, 2025 08:05AM
Jan 13, 2025 08:05AM
Jan 13, 2025 08:05AM Rigel Provides Business Update and 2025 Outlook
Jan 9, 2025 08:05AM
Dec 9, 2024 12:02PM
Dec 9, 2024 12:02PM
Dec 2, 2024 08:05AM
Dec 2, 2024 08:05AM
Nov 7, 2024 04:01PM
Nov 5, 2024 09:05AM Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
Oct 24, 2024 04:36PM
Oct 24, 2024 04:35PM
Oct 16, 2024 10:01AM
Oct 16, 2024 10:00AM
Sep 5, 2024 07:30AM
Sep 3, 2024 08:03AM
Sep 3, 2024 08:00AM Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
Aug 6, 2024 04:01PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All